Class Action Deadline Looms for uniQure Investors Amid FDA Approval Claims
uniQure faces securities class action over allegedly misleading FDA approval claims and timeline delays. Investors must act before April 13, 2026 deadline.
QUREVTGNLUinvestor lossessecurities class action